TOLERO PHARMACEUTICALS - Trademark Details
Status: 710 - Cancelled - Section 8
Serial Number
86418815
Registration Number
4751574
Word Mark
TOLERO PHARMACEUTICALS
Status
710 - Cancelled - Section 8
Status Date
2021-12-10
Filing Date
2014-10-08
Registration Number
4751574
Registration Date
2015-06-09
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2015-03-24
Attorney Name
Law Office Assigned Location Code
L80
Employee Name
BUSH, KAREN K
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"PHARMACEUTICALS"
Goods and Services
Bacteriological research; Bacteriological research and testing; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical analysis; Chemical engineering; Chemical laboratories; Chemical research; Chemical, biochemical, biological and bacteriological research and analysis; Chemist services; Conducting clinical trials for others; Conducting early evaluations in the field of new pharmaceuticals; Consultancy pertaining to pharmacology; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of new technology for others in the field of pharmacology; Development of pharmaceutical preparations and medicines; Drug discovery services; Executing of chemical analyses; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Genetic testing of laboratory animals for research purposes; Laboratory analysis in the field of pharmacology; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of pharmacology; Medical and scientific research information in the field of pharmacology; Medical and scientific research, namely, conducting clinical trials for others; Medical laboratory services; Medical research; Medical research services in the field of cancer; Performance of chemical analyses; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical testing services and information in the field of cancer research and disease classification; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of chemistry; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Scientific research in the field of genetics and genetic engineering; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Working on and evaluation of chemical analyses; Working on and evaluation of chemical syntheses
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2021-12-10
Primary Code
042
First Use Anywhere Date
2011-08-01
First Use In Commerce Date
2011-08-01
Correspondences
Name
Howard N. Aronson
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2014-10-11 | NEW APPLICATION ENTERED IN TRAM |
2014-10-15 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2015-01-27 | ASSIGNED TO EXAMINER |
2015-01-27 | EXAMINERS AMENDMENT -WRITTEN |
2015-01-27 | EXAMINERS AMENDMENT E-MAILED |
2015-01-27 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2015-01-27 | EXAMINER'S AMENDMENT ENTERED |
2015-01-27 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2015-02-13 | ASSIGNED TO LIE |
2015-02-14 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2015-03-04 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2015-03-24 | PUBLISHED FOR OPPOSITION |
2015-03-24 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2015-06-09 | REGISTERED-PRINCIPAL REGISTER |
2017-12-13 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
2018-02-09 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2018-02-09 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2020-06-09 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
2021-12-10 | CANCELLED SEC. 8 (6-YR) |